IP Library Granted Patent US 8,372,648
Granted Patent B2
US 8,372,648 · App. 11/954,030 · Granted Feb 12, 2013

Optical reporter compositions

Inventors: Thomas Kwok (Stony Brook, NY); Ming-Hwa Liang (Stony Brook, NY); Stephane Shu Kin So (Stony Brook, NY)
Assignee: APDN (B.V.I.), Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,372,648
App. No.
11/954,030
Granted
Feb 12, 2013
Kind
B2
Abstract

This invention provides compositions that have a light emitting reporter linked to biomolecules, preferably, nucleotide oligomers. The light reporter particles are silylated and functionalized to produce a coated light reporter particle, prior to covalently linking the biomolecules to the light reporter particle. The light reporter particles of the invention can be excited by a light excitation source such as UV or IR light, and when the biomolecule is DNA, the attached DNA molecule(s) are detectable by amplification techniques such as PCR.

Claims (54)

1. A composition of the formula I:

(cOpR)-[L-(NA)] m   I

wherein:

m is an integer greater than 1;

(cOpR) is a coated optical reporter particle comprising an upconverting phosphor (UCP) of the formula Na (Y x Yb y Er z ) F 4 ;

(NA) is a nucleic acid oligomer of detectable sequence, said (NA) is a double stranded DNA molecule having a length of between 40 base pairs and 1000 base pairs; and

L is a linking group covalently bound to the coated optical reporter particle and to the nucleic acid oligomer, said linking group L comprises an alkylene moiety having a first end covalently bound to the coated optical reporter particle and a second end covalently bound to the nucleic acid oligomer.

2. The composition of claim 1 , wherein

x is from about 0.6 to about 0.95;

y is from about 0.05 to about 0.35; and

z is from about 0.1 to about 0.001.

3. The composition of claim 1 , wherein L is of the formula:

-A-R 1 —B—

wherein:

R 1 is C 2-8 alkylene;

-A- is a group covalently bonded to the surface of the coated optical reporter; and

—B— is a group covalently bonded to the 3′ or 5′ end of the nucleic acid oligomer.

4. The composition of claim 3 , wherein -A- is —O—.

5. The composition of claim 3 , wherein —R 1 — is —(CH 2 ) n - and wherein n is from 2 to 8.

6. The composition of claim 3 , wherein —B— is:

—S—;

—O—;

—NR a —;

—S—(CH 2 ) p —;

—O—(CH 2 ) p —;

—NR a —(CH 2 ) p —;

—S—(CH 2 ) q —C(O)—NR a —(CH 2 ) p —;

—O—(CH 2 ) q —C(O)—NR a —(CH 2 ) p —;

—NR a —(CH 2 ) q —C(O)—NR a —(CH 2 ) p —;

—S—C(O)—(CH 2 ) r —C(O)—NR a —(CH 2 ) p —;

—O—C(O)—(CH 2 ) r —C(O)—NR a —(CH 2 ) p —; or

—NR a —C(O)—(CH 2 ) r —C(O)—NR a —(CH 2 ) p —;

wherein:

p is from 2 to 8;

q is from 1 to 8;

r is from 2 to 8; and

each R a is independently hydrogen or C 1-6 alkyl.

7. The composition of claim 3 , wherein —B— is:

—S—(CH 2 ) q —C(O)—NR a —(CH 2 ) p or

—N R a —C(O)—(CH 2 ) r —C(O)—NR a —(CH 2 ) p —;

wherein p, q, r and R a are as recited in claim 6 .

8. The composition of claim 7 , wherein:

p is from 2 to 6;

q is from 1 to 3; and

r is 2 or 3.

9. The composition of claim 3 , wherein —B— is:

—S—CH 2 —C(O)—NH—(CH 2 ) 6 —; or

—NH—C(O)—(CH 2 ) 3 —C(O)—NH—(CH 2 ) 6 —.

10. The composition of claim 1 , wherein the cOpR is coated with silica.

11. The composition of claim 10 , wherein the silica comprises at least one Si—O bond.

12. The composition of claim 1 , wherein the NA is double stranded DNA molecule identifiable by real time PCR without DNA sequencing.

13. The composition of claim 1 , wherein the NA is a DNA molecule having a length of between 80 base pairs and 500 base pairs.

14. The composition of claim 1 , wherein said nucleic acid oligomer is identifiable by a method comprising polymerase chain reaction amplification while said oligomer is covalently attached to said coated optical reporter particle.

15. The composition of claim 14 , wherein said polymerase chain reaction amplification produces one or more amplicons and the size of said one or more amplicons is determined by a method comprising capillary electrophoresis.

Assignments (7)
SECURITY INTEREST Recorded Oct 12, 2020
From: DELAWARE TRUST COMPANY
To: APDN (B.V.I.) INC.
Reel/Frame 054047/0148 →
SECURITY INTEREST Recorded Feb 27, 2019
From: APDN (B.V.I.) INC.
To: DELAWARE TRUST COMPANY
Reel/Frame 048460/0095 →
SECURITY INTEREST Recorded Feb 27, 2019
From: APDN (B.V.I.) INC.
To: DELAWARE TRUST COMPANY
Reel/Frame 048460/0160 →
RELEASE OF SECURITY INTEREST Recorded Apr 9, 2012
From: ETICO CAPITAL, LLC
To: APDN (B.V.I.) INC.
Reel/Frame 028014/0837 →
PATENT SECURITY AGREEMENT Recorded Jul 19, 2010
From: APDN (B.V.I.) INC.
To: ETICO CAPITAL, LLC
Reel/Frame 024710/0239 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2010
From: APPLIED DNA SCIENCES, INC.
To: APDN (B.V.I.) INC.
Reel/Frame 024559/0110 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 11, 2008
From: KWOK, THOMAS; LIANG, MING-HWA; SHU KIN SO, STEPHANE
To: APPLIED DNA SCIENCES, INC.
Reel/Frame 021225/0608 →
Continuity (8)
Continuation In Part 11437265 · May 19, 2006
Continuation In Part 10825968 · Apr 15, 2004
Provisional Application 60682976 · May 20, 2005
Provisional Application 60463215 · Apr 16, 2003
Provisional Application 60874425 · Dec 12, 2006
Provisional Application 60877875 · Dec 29, 2006
Provisional Application 60877869 · Dec 29, 2006
Related Publication 20080299667A1 · Dec 4, 2008